After a certain age, approximately 40% of people experience some degree of hearing loss. While age-related hearing loss is most prevalent in adults over the age of 65, it can start occurring far earlier than that, when people ...
The clinical knowledge and reasoning skills of GPT-4 are approaching the level of specialist eye doctors, a study led by the University of Cambridge has found.
Apr 17, 2024
0
72
An estimated 5% to 10% of blindness worldwide is due to the rare inflammatory eye disease uveitis. Intermediate uveitis is often associated with a chronic course of the disease and the need for immunosuppressive therapy. ...
Jan 30, 2024
0
21
Researchers at Moorfields Eye Hospital and UCL Institute of Ophthalmology have developed an artificial intelligence (AI) system that has the potential to not only identify sight-threatening eye diseases but also predict general ...
Sep 13, 2023
0
71
Markers that indicate the presence of Parkinson's disease in patients on average seven years before clinical presentation have been identified by a UCL and Moorfields Eye Hospital research team.
Aug 21, 2023
0
338
While early treatment of diabetes-related eye disease slowed progression to severe disease, it did not improve visual acuity compared with treating more severe disease once it developed, according to a clinical study from ...
Feb 7, 2023
0
61
A recent study by York University researchers suggests an innovative artificial intelligence (AI) technique they developed is considerably more effective than the human eye when it comes to predicting therapy outcomes in ...
Dec 19, 2022
0
85
An interdisciplinary research team led by UCLA found that a drug already approved by the Food and Drug Administration for eye disease, verteporfin, stopped the replication of SARS-CoV-2, the virus that causes COVID-19. Their ...
Nov 8, 2022
0
51
Researchers at an EPFL lab have developed an ophthalmological device that can be used to diagnose some degenerative eye disorders long before the onset of the first symptoms. In early clinical trials, the prototype was shown ...
Oct 28, 2022
0
21
New research has laid the groundwork for a long-lasting eye drop to treat corneal neovascularisation (CoNV), a condition which affects more than a million people globally each year.
Jan 25, 2022
0
99
